What is the recommended management for a patient with pain and nausea, including opioid analgesia, antiemetic therapy, and necessary monitoring?

Management of Pain and Nausea

For patients experiencing pain and nausea, initiate opioid analgesia according to the WHO pain ladder while simultaneously starting prophylactic antiemetic therapy with metoclopramide or a dopamine antagonist, as opioid-induced nausea occurs in up to 50% of patients and should be anticipated and prevented rather than treated reactively.

Opioid Analgesia Selection

Mild to Moderate Pain (WHO Level I-II)

• Start with acetaminophen/paracetamol (up to 4-6 grams daily) or NSAIDs for mild pain 1
• For moderate pain, add weak opioids: codeine, dihydrocodeine (60-120 mg), or tramadol (50-100 mg) 2, 1
• Critical caveat: Tramadol must not be combined with MAO inhibitors and requires caution with antidepressants due to seizure risk 2
• Always anticipate constipation with codeine 2

Moderate to Severe Pain (WHO Level III)

Oral morphine is the first-line strong opioid of choice 2. This is a standard recommendation across all major guidelines.

Starting doses without prior opioid exposure:

• Immediate-release morphine: 20-40 mg orally 3
• For severe pain requiring rapid control: IV morphine 1.5 mg every 10 minutes until relief 4
• The oral to IV conversion ratio is 3:1 4

Titration protocol:

• Prescribe around-the-clock dosing with sustained-release formulations 1, 3
• Always provide breakthrough doses equivalent to 10-15% of total daily dose 1, 4
• If more than 4 breakthrough doses needed per 24 hours, increase baseline dose 1, 3
• Use immediate-release formulations for breakthrough pain due to rapid onset 2

Alternative Strong Opioids

When morphine fails or causes intolerable side effects:

• Hydromorphone or oxycodone for morphine intolerance 2
• Transdermal fentanyl only for stable pain (≥60 mg/day morphine equivalent) 3, 5
• Methadone requires experienced prescribers due to variable half-life and complex conversion ratios (1:5 to 1:12) 4

Antiemetic Management

Prophylactic Approach

Start antiemetics at opioid initiation, not after nausea develops 6. This is critical because nausea occurs at doses lower than those achieving analgesia 7.

First-line prophylactic agents:

• Metoclopramide (central and peripheral effects, recommended as first-line for chronic nausea including opioid-related) 6, 8
• Prochlorperazine around-the-clock for first few days, then wean 6
• Dopamine antagonists target the chemoreceptor trigger zone mechanism 6

Evidence note: While prophylactic ondansetron is commonly used, recent high-quality evidence from 2026 shows it provides no benefit for opioid-induced nausea in unselected patients 9. However, it remains effective for established nausea 6.

Treatment of Established Nausea

If nausea develops despite prophylaxis:

1. Rule out constipation first - the most common cause 6
2. Metoclopramide for ongoing nausea 8
3. Ondansetron (5-HT3 antagonist) for breakthrough episodes 6
4. Haloperidol for refractory cases 1, 3
5. Consider opioid rotation if nausea persists, as different opioids have varying emetogenic profiles 4, 6

Important: Tolerance to nausea typically develops within days 3, 6, so aggressive early management improves adherence.

Mandatory Concurrent Management

Constipation Prevention

Begin prophylactic bowel regimen immediately when starting opioids 6. This is non-negotiable.

• Prevention: Senna with or without docusate daily, titrated to achieve bowel movement every 1-2 days without straining 6
• Treatment: Once constipation occurs, add magnesium-based products and bisacodyl 6
• Refractory cases: Consider peripherally acting mu-opioid receptor antagonists (PAMORAs) like methylnaltrexone, naldemedine, or naloxegol 6

Monitoring Requirements

• Daily assessment during initial titration, especially for home patients 2
• Monitor for sedation, respiratory depression (preceded by sedation), and CNS toxicity 1, 3
• Never stop opioids abruptly - taper by 30-50% weekly if discontinuation needed 2
• Keep naloxone available for reversal of severe overdose 1, 3

Critical Pitfalls to Avoid

1. Do not mix opioid receptor types (pure agonist with partial agonist-antagonist) 2
2. Do not use intramuscular injections - painful with no pharmacokinetic advantage 1, 10
3. Do not wait for nausea to develop before starting antiemetics 6, 11
4. Do not underdose breakthrough medication - inadequate rescue doses lead to poor pain control 2
5. Do not ignore new-onset sedation with stable opioid dosing - usually indicates drug interactions or metabolite accumulation 6

When Oral Route Impossible

Preferred alternatives 2:

• Transdermal fentanyl for stable pain
• Continuous subcutaneous morphine (simple, effective, first-choice parenteral route) 4
• IV infusion when subcutaneous contraindicated (edema, coagulation disorders, high volume needs) 4

The subcutaneous route is as effective as IV with similar dosing but slower onset 4.